[Current status of pathobiochemistry and clinico-chemical laboratory diagnosis of liver fibrosis].

Suppr

超能文献

作者信息

Gressner A M

出版信息

Med Klin (Munich). 1987 Oct 2;82(20):700-10.

PMID:3316964

Abstract

摘要

相似文献

[Current status of pathobiochemistry and clinico-chemical laboratory diagnosis of liver fibrosis].

Med Klin (Munich). 1987 Oct 2;82(20):700-10.

Liver extracellular matrix in health and disease.

J Pathol. 2003 Jul;200(4):504-15. doi: 10.1002/path.1397.

Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.

Best Pract Res Clin Gastroenterol. 2009;23(3):453-60. doi: 10.1016/j.bpg.2009.03.002.

[Liver fibrosis].

Ann Pathol. 1995;15(5):372-9.

[Fibronectin--a key substance in pathogenesis of liver cirrhosis?].

Leber Magen Darm. 1993 Dec;23(6):239-42.

[Current findings in hepatic fibrogenesis].

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1990 Mar-Apr;42(2):111-8.

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

N Engl J Med. 1993 Jun 24;328(25):1828-35. doi: 10.1056/NEJM199306243282508.

Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.

Clin Chim Acta. 2007 Jun;381(2):107-13. doi: 10.1016/j.cca.2007.02.038. Epub 2007 Feb 27.

Cell interactions with the extracellular matrix.

Cell Tissue Res. 2010 Jan;339(1):1-5. doi: 10.1007/s00441-009-0891-x.

Genesis of hepatic fibrosis and its biochemical markers.

Scand J Clin Lab Invest. 2008;68(4):260-9. doi: 10.1080/00365510701668516.

引用本文的文献

Hepatic fibrosis--current concepts of pathogenesis and therapy.

Gastroenterol Jpn. 1993 Aug;28(4):570-9.

Aetiology and pathophysiology of chronic liver disorders.

Drugs. 1990;40 Suppl 3:3-22. doi: 10.2165/00003495-199000403-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Current status of pathobiochemistry and clinico-chemical laboratory diagnosis of liver fibrosis].

Med Klin (Munich). 1987 Oct 2;82(20):700-10.

Liver extracellular matrix in health and disease.

J Pathol. 2003 Jul;200(4):504-15. doi: 10.1002/path.1397.

Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.

Best Pract Res Clin Gastroenterol. 2009;23(3):453-60. doi: 10.1016/j.bpg.2009.03.002.

[Liver fibrosis].

Ann Pathol. 1995;15(5):372-9.

[Fibronectin--a key substance in pathogenesis of liver cirrhosis?].

Leber Magen Darm. 1993 Dec;23(6):239-42.

[Current findings in hepatic fibrogenesis].

Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1990 Mar-Apr;42(2):111-8.

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

N Engl J Med. 1993 Jun 24;328(25):1828-35. doi: 10.1056/NEJM199306243282508.

Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.

Clin Chim Acta. 2007 Jun;381(2):107-13. doi: 10.1016/j.cca.2007.02.038. Epub 2007 Feb 27.

Cell interactions with the extracellular matrix.

Cell Tissue Res. 2010 Jan;339(1):1-5. doi: 10.1007/s00441-009-0891-x.

Genesis of hepatic fibrosis and its biochemical markers.

Scand J Clin Lab Invest. 2008;68(4):260-9. doi: 10.1080/00365510701668516.

引用本文的文献

Hepatic fibrosis--current concepts of pathogenesis and therapy.

Gastroenterol Jpn. 1993 Aug;28(4):570-9.

Aetiology and pathophysiology of chronic liver disorders.

Drugs. 1990;40 Suppl 3:3-22. doi: 10.2165/00003495-199000403-00003.